In this study, we combined The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) to investigate abnormal expression and to assess its prognostic value in multiple cancer types, providing a comprehensive picture of the prognostic value and alteration of the IDO1 gene in pan-cancer. The gene discussed is IDO1; the disease is cancer.